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Welcome to the journal and some
history
Welcome to the new Journal of Tissue Engineering and
Regenerative Medicine! It is, believe me, with great
pleasure and some emotion that I write these words.
It has been a long time since I, with some colleagues and
collaborators, recognized the need for having a strong
new journal in the field of tissue engineering, regenerative
medicine, stem cells and biomedical materials. The first
discussions on this took place, if I remember it well, in
2002.Whenwe applied to create the European Network of
Excellence (NoE) on Tissue Engineering – EXPERTISSUES
(http://www.expertissues.org) – we included as one of
the main goals and deliverables the creation of a new
international journal in the field of tissue engineering and
regenerative medicine. The NoE was funded, in a very
competitive selection process, by the Sixth Framework
program (FP6) of the European Commission (EC), being
the only European network of excellence in the field of
tissue engineering. We all immediately agreed that a new
journal, in this very competitive and rapidly evolving area,
would need a main publishing house supporting it. The
EXPERTISSUES project started in October 2004. The first
proposal to John Wiley & Sons Ltd was made in late
2005, we reached agreement in April 2006, and now here
we are, fully committed to making this journal a great
success!
All the research team leaders of EXPERTISSUES (from
20 Institutions in 13 countries), which I have the pleasure
to coordinate, are members of the Editorial Board of the
journal. This initial informal connection of the journal to
the NoE will help to ensure a steady flow of good papers
that is so important to launching a new journal, but it must
be stressed that the journal is fully international, as can
easily be seen from the composition of the Editorial Board.
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The Editorial Board
The journal has a strong senior editorial board composed
of four very active scientists, whose work is of exemplary
quality and with complementary expertise. I come
from a biomaterials and scaffolds background and my
multidisciplinary group spans frommaterials, to biological
approaches, to in vitro and in vivo tests. I am the CEO for
the European Institute of Excellence in Tissue Engineering
and Regenerative Medicine Research.
As Editor-in-Chief, I am supported by three renowned
Associate Editors. Prof. Sam I. Stupp from Northwestern
University needs no introduction being one of the most
recognized and established Professors in the field of
Regenerative Medicine. He is presently the Board of
Trustees Professor of Science, Chemistry and Medicine
and Director of the Institute for BioNanotechnology
in Medicine at Northwestern University, Chicago, USA.
Dr. Hajime Ohgushi is the Director of the Tissue
Engineering Research Group at the Research Institute for
Cell Engineering (RICE) of AIST (Advanced Institute for
Science and Technology), in Osaka, Japan. Although still
quite young, he is one of the most recognized scientists
in Japan in the field of clinical applications of stem cells
and tissue engineering. Finally, Prof. Anthony Atala is
one of the world leaders in the field of tissue engineering
and regenerative medicine. As the Director of the Wake
Forest Institute for Regenerative Medicine (one of the
main initiatives in regenerative medicine in the USA) he
is an international leader in the translation of scientific
discovery into clinical therapies.
The Editorial Board comprises the majority of the most
dynamic and active researchers in all the fields rele-
vant to the journal. Members were selected based on an
evaluation of the scientific production, in the last few
years, of the researchers working in the field. Their excel-
lence, multidisciplinarity, dynamism, and ambition are
perfectly suited to our aims for this journal. In many
cases the members of the Editorial Board are members
of the directing boards of international societies, which
will allow us to stay in touch with the needs of each
aspect of the community. Since the Journal of Tissue
Engineering and Regenerative Medicine aims to serve the
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entire multidisciplinary community in this area, it will not
be forming affiliations to any specific scientific society.
Rather, we will offer reduced subscription rates as a ben-
efit to the members of any society that wishes us to do so.
Aims and scope and coverage
The Journal of Tissue Engineering and Regenerative
Medicine publishes articles on topics relevant to the
development of therapeutic approaches that combine
stem or progenitor cells, biomaterials and scaffolds,
growth factors and other bioactive agents, and their
respective constructs. All papers should deal with research
that has a direct or potential impact on the development
of novel clinical approaches for the regeneration or repair
of tissues and organs.
The journal is multidisciplinary, covering the combi-
nation of the principles of life sciences and engineering
in efforts to advance medicine and clinical strategies.
It focuses on the use of cells, materials, and biochemi-
cal/mechanical factors in the development of biological
functional substitutes that restore, maintain or improve
tissue or organ function. The Journal of Tissue Engineering
and RegenerativeMedicine publishes research on any tissue
or organ and covers all key aspects of the field, including
the development of new biomaterials and processing of
scaffolds; the use of different types of cells (mainly stem
and progenitor cells) and their culture in specific biore-
actors; studies in relevant animal models; and clinical
trials in human patients performed under strict regu-
latory and ethical frameworks. Manuscripts describing
the use of advanced methods for the characterization of
engineered tissues are also of special interest to the jour-
nal readership, and emphasis will also be given to the
development of new materials and scaffolds and to the
use of different types of stem and progenitor cells and
pathways for controlling their differentiation. Typically,
papers presenting the design, development or refinement
of biomaterials or scaffolds will only be considered when
these have been tested for their ability to support cellu-
lar attachment/interaction and/or growth, development
and differentiation. With regard to ethical considerations,
human investigation and animal experiments must always
have local ethics committee approval and must meet rel-
evant national and international ethical standards.
In fact, we are aiming for a readership of cell and
molecular biologists, materials and biomaterials scientists,
biomedical engineers, chemists, medical researchers,
clinicians and surgeons specialising in chronic and
degenerative diseases, on cell therapies and trauma
surgery. We foresee that the journal will incorporate
the fields of biomaterials, stem cells, drug delivery,
biotechnology, nanomedicine, tissue engineering and
regenerative medicine.
The scope of TERM includes, among others, the
following not so usual topics:
– Design of hybridmaterials, in the sense of cell-material
constructs
– Integrative knowledge on the interactions between
cells and materials
– Characterization of the properties of systems designed
for regenerative medicine
– Use of combinatorial approaches to design for
regenerative medicine strategies
– Cell biology in understanding the biological response
to materials
– Design of biomaterials and scaffolds to achieve specific
functionalities
– In vivo response to multifunctional constructs
Other relevant topics include:
– Interactions between cells and constructs
– Surface modification technologies
– In vitro and in vivo approaches
– Controlled/sustained release strategies
– Development of carrier systems
– Nanotechnology and/or non-invasive approaches
– Smart systems, including self-assembly materials
– Cell types, manipulation of cells and bioreactors
Types of articles to be published
Journal of Tissue Engineering and Regenerative Medicine
will publish a broad range of article types:
– Original research articles
– Short communications or short reports aimed at rapid
publication of highly relevant findings
– Authoritative review papers by world recognized
experts (invited reviews) or relevant researchers that
wish to submit a review
– Perspectives (short reviews) presenting an outlook on
the future direction of a chosen area of the field
– Clinical case studies reporting recent tests and clinical
trials in patients of new tissue engineering and
regenerative medicine approaches.
This wider range of article types will promote the sharing
of knowledge and opinions, the establishment of good
practice and discussion of emerging topics, while ensur-
ing that researchers may rapidly publish highly original
findings. You will find examples of four of these types of
papers in this first issue and the first two short communica-
tions will appear in issue 2. More details on the criteria for
these different article types can be found in the instruc-
tions for authors. It is also important to highlight that
the journal will adopt a flexible structure regarding the
distribution of the five different article types in each issue.




• A strong international multidisciplinary Editorial Board
and highly respected Senior Editors
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• Worldwide visibility due to Complimentary Online
Access to full-text of all articles published in 2007
(www.interscience.wiley.com/journal/term)
• Rapid but demanding peer review and
publication
• An online manuscript submission and tracking
process
• The potential to rapidly become one of the best journals
in the field
• A multidisciplinary readership.
The journal will publish articles online as fast as
possible (while of course maintaining the quality of
the review process) and will ensure a very fast
review for short communications. The use of the well
established online submission system Manuscript Central
(http://mc.manuscriptcentral.com/term) will make all
this smooth and achievable. Of course the fact that the
journal is being launched by one of the strongest scientific
publishers in the world, with a level of experience that
is reflected in the fact that they are celebrating their
bicentennial in 2007, will clearly be instrumental in the
success of this journal.
To ensure that everyone has the opportunity to
evaluate Journal of Tissue Engineering and Regenerative
Medicine we are offering complimentary online access
to the full-text of all articles published in 2007 for
those Institutions who choose to take advantage of it.
In order to access the journal, you just have to ask
your librarian to Opt-in for online access by visiting:
http://www.interscience.wiley.com/newjournals, or of
course by contacting their Wiley InterScience Account
Manager. This policy will also benefit our authors by
dramatically increasing the visibility of their papers.
The first issues of the Journal of
Tissue Engineering and Regenerative
Medicine
We hope you will enjoy our inaugural issue as much as
we have enjoyed preparing it. It contains 2 reviews, 1
perspective, 4 research articles and 1 clinical case report.
The accepted works come from some major groups with
senior authors including Paul Ducheyne, Klaas de Groot,
John Jansen, David L. Kaplan, Catherine Verfaillie, Ivan
Martin, Hajime Ohgushi and myself. The topics of the
manuscripts are, as promised, multidisciplinary and of
interest to a wide range of readers.
We have equally important articles to come in the
following issues. Issue 2 will start with a leading review
by Anthony Atala, and will include manuscripts with
senior authors including Paul Ducheyne, Julio San Roman,
Michael Sefton, John Jansen, Chikara Ohtsuki, Jons
Hilborn, Karen Burg and myself. For issue 3 we already
have a very interesting perspective article ‘‘A proposed
definition for regenerative medicine’’ and articles from
some other major groups, such as those of Clemens van
Blitterswijk, Robert Brown and Fu Zhai Cui.
I am sure that you will enjoy the contents of our new
Journal of Tissue Engineering and Regenerative Medicine.
The editorial team and the publisher are committed to
making it a leading journal, to obtaining listing by ISI
and PubMed/Medline as fast as possible, and of course
to reaching a high impact factor. Just Opt-In for the
complimentary access, you won’t regret it! Also please
consider submitting your next paper to our journal, we
have a broad readership, a rapid review process and you
can trust that this will become a leading journal. . .
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